Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with an IPO date between 2020 and 2024, returning 11,988.3%.

ASSET	% RETURN
Regencell Bioscience (RGC)	11,988.32%
QMMM Holdings Limited Ordinary Shares (QMMM)	9,155.81%
HCM II Acquisition (HONDW)	5,331.03%
DeFi Development (DFDV)	2,310.46%
USA Rare Earth (USARW)	2,195%
Spring Valley Acquisition Corp II Warrant (SVIIW)	1,880.77%
Above Food Ingredients Inc Warrants (ABVEW)	1,441.82%
TMC the metals company Inc Warrants (TMCWW)	1,154.72%
Oncology Institute (TOIIW)	1,090.48%
Abivax SA American Depositary Shares (ABVX)	1,044.61%
Oncology Institute (TOI)	1,024.18%
Critical Metals Corp Warrants (CRMLW)	922.98%
Lizhi (SOGP)	904.11%
Vine Hill Capital Investment Corp Warrant (VCICW)	887.5%
BT Brands Inc Warrant (BTBDW)	883.06%
Global Interactive Technologies (GITS)	846.06%
CEA Industries (BNCWW)	738.26%
Wearable Devices (WLDSW)	711.32%
GSR III Acquisition Corp Right (GSRTR)	701.8%
Dave Inc Warrants (DAVEW)	615.18%
Spring Valley Acquisition Corp II Rights (SVIIR)	561.25%
Nanobiotix (NBTX)	539.23%
ThredUp (TDUP)	534.72%
Better Home & Finance (BETR)	524.69%
TMC the metals (TMC)	524.56%